EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C29H29F3N8O |
| Net Charge | 0 |
| Average Mass | 562.600 |
| Monoisotopic Mass | 562.24164 |
| SMILES | Cc1ncc(NC(=O)c2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cccnc2)n1 |
| InChI | InChI=1S/C29H29F3N8O/c1-19-26(38-28-34-9-7-25(37-28)21-4-3-8-33-16-21)15-23(17-35-19)36-27(41)20-5-6-22(24(14-20)29(30,31)32)18-40-12-10-39(2)11-13-40/h3-9,14-17H,10-13,18H2,1-2H3,(H,36,41)(H,34,37,38) |
| InChIKey | BJCJYEYYYGBROF-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | apoptosis inducer Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms. EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor An EC 2.7.10.* (protein-tyrosine kinase) inhibitor that specifically blocks the action of non-specific protein-tyrosine kinase (EC 2.7.10.2). |
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| flumatinib (CHEBI:233593) has role antineoplastic agent (CHEBI:35610) |
| flumatinib (CHEBI:233593) has role apoptosis inducer (CHEBI:68495) |
| flumatinib (CHEBI:233593) has role EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor (CHEBI:76617) |
| flumatinib (CHEBI:233593) is a (trifluoromethyl)benzenes (CHEBI:83565) |
| flumatinib (CHEBI:233593) is a N-methylpiperazine (CHEBI:46920) |
| flumatinib (CHEBI:233593) is a aminopyridine (CHEBI:38207) |
| flumatinib (CHEBI:233593) is a aminopyrimidine (CHEBI:38338) |
| flumatinib (CHEBI:233593) is a benzamides (CHEBI:22702) |
| flumatinib (CHEBI:233593) is a secondary amino compound (CHEBI:50995) |
| flumatinib (CHEBI:233593) is a secondary carboxamide (CHEBI:140325) |
| IUPAC Name |
|---|
| 4-[(4-methylpiperazin-1-yl)methyl]-N-(6-methyl-5-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}pyridin-3-yl)-3-(trifluoromethyl)benzamide |
| INNs | Source |
|---|---|
| flumbatinib | WHO MedNet |
| flumbatinib | WHO MedNet |
| flumbatinib | WHO MedNet |
| flumbatinibum | WHO MedNet |
| Synonyms | Source |
|---|---|
| HHGV678 | ChEBI |
| HH-GV678 | DrugBank |
| HH-GV-678 | ChEBI |
| 4-[(4-methyl-1-piperazinyl)methyl]-N-[6-methyl-5-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-3-pyridinyl]-3-(trifluoromethyl)-benzamide | ChEBI |
| HHGV 678 | ChEBI |
| Citations |
|---|